Jun11165
Jun11165 is a SARS-CoV-2 PLpro inhibitor (IC50 ≤ 0.6 μM), which inhibits SARS-CoV-2 with an EC50 value of ≤ 6 μM. Jun11165 can be used in the research of viral infections[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/jun11165.html
Solubility
10 mM in DMSO
Smiles
C[C@@H](NC(C1=CC(OCCN)=CC=C1C)=O)C2=CC(C3=CSC=C3)=CC=C2
Molecular Formula
C22H24N2O2S
Molecular Weight
380.50
References & Citations
[1]Jadhav P, et al. Structure-based design of SARS-CoV-2 papain-like protease inhibitors. Eur J Med Chem. 2023 Dec 5;264:116011.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7142016 Inquire
Rabbit anti-Schizosaccharomyces pombe (strain 972/24843)(Fission yeast) SNX3 Polyclonal Antibody
Ask
View Details EK5F684-01 48 Test
Mouse Insulin Like Growth Factor Binding Protein 7 (IGFBP7) ELISA Kit-Sandwich
Ask
View Details EK5F684-02 96 Tests
Mouse Insulin Like Growth Factor Binding Protein 7 (IGFBP7) ELISA Kit-Sandwich
Ask
View Details MBS1300100-01 0.02 mg (E-Coli)
Recombinant Coxiella burnetii UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC)
Ask
View Details ![Recombinant Coxiella burnetii UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC)](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
MBS1300100-02 0.02 mg (Yeast)
Recombinant Coxiella burnetii UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC)
Ask
View Details